{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=vortioxetine+10+mg+tablet", "query": { "intervention": "vortioxetine 10 mg tablet" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 15, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=vortioxetine+10+mg+tablet&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-28T19:34:21.515Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02709655", "title": "Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Depressive Disorder, Major" ], "interventions": [ { "name": "Vortioxetine 10 mg/day", "type": "DRUG" }, { "name": "Vortioxetine 20 mg/day", "type": "DRUG" }, { "name": "Fluoxetine 20mg/day", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "H. Lundbeck A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "7 Years to 11 Years" }, "enrollment_count": 683, "start_date": "2016-05-18", "completion_date": "2022-01-21", "has_results": true, "last_update_posted_date": "2022-09-22", "last_synced_at": "2026-09-28T19:34:21.515Z", "location_count": 34, "location_summary": "Little Rock, Arkansas • Imperial, California • Lemon Grove, California + 29 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Imperial", "state": "California" }, { "city": "Lemon Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02709655" }, { "nct_id": "NCT01364649", "title": "Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Treatment Outcome" ], "interventions": [ { "name": "Vortioxetine", "type": "DRUG" }, { "name": "Escitalopram", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 447, "start_date": "2011-06", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2014-10-09", "last_synced_at": "2026-09-28T19:34:21.515Z", "location_count": 53, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Anaheim, California + 50 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Chino", "state": "California" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01364649" }, { "nct_id": "NCT02327013", "title": "Investigating the Effect of Vortioxetine in Adult ADHD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Attention Deficit Hyperactivity Disorder" ], "interventions": [ { "name": "vortioxetine 10 mg tablet", "type": "DRUG" }, { "name": "vortioxetine 20 mg tablet", "type": "DRUG" }, { "name": "Placebo tablet", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "H. Lundbeck A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 227, "start_date": "2014-12", "completion_date": "2016-09", "has_results": true, "last_update_posted_date": "2018-03-07", "last_synced_at": "2026-09-28T19:34:21.515Z", "location_count": 15, "location_summary": "Beverly Hills, California • Garden Grove, California • National City, California + 11 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "Bradenton", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02327013" }, { "nct_id": "NCT02972632", "title": "Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Vortioxetine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 123, "start_date": "2016-12-22", "completion_date": "2018-02-06", "has_results": true, "last_update_posted_date": "2019-07-11", "last_synced_at": "2026-09-28T19:34:21.515Z", "location_count": 25, "location_summary": "Costa Mesa, California • Culver City, California • Glendale, California + 22 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Culver City", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02972632" }, { "nct_id": "NCT01163266", "title": "Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Depressive Disorder, Major" ], "interventions": [ { "name": "Vortioxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 462, "start_date": "2010-07", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2013-12-18", "last_synced_at": "2026-09-28T19:34:21.515Z", "location_count": 39, "location_summary": "Anaheim, California • Cerritos, California • Costa Mesa, California + 36 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Garden Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01163266" }, { "nct_id": "NCT01153009", "title": "Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Depressive Disorder, Major" ], "interventions": [ { "name": "Vortioxetine", "type": "DRUG" }, { "name": "Duloxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 614, "start_date": "2010-06", "completion_date": "2012-03", "has_results": true, "last_update_posted_date": "2013-12-18", "last_synced_at": "2026-09-28T19:34:21.515Z", "location_count": 56, "location_summary": "Beverly Hills, California • Chino, California • Garden Grove, California + 53 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Chino", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Los Alamitos", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01153009" }, { "nct_id": "NCT00707980", "title": "Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Vortioxetine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "76 Years", "sex": "ALL", "summary": "18 Years to 76 Years" }, "enrollment_count": 836, "start_date": "2008-06", "completion_date": "2010-08", "has_results": true, "last_update_posted_date": "2013-12-13", "last_synced_at": "2026-09-28T19:34:21.515Z", "location_count": 38, "location_summary": "Beverly Hills, California • Irvine, California • Santa Ana, California + 35 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00707980" }, { "nct_id": "NCT02871297", "title": "Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Depressive Disorder, Major" ], "interventions": [ { "name": "Vortioxetine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "H. Lundbeck A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "7 Years to 18 Years" }, "enrollment_count": 662, "start_date": "2016-08-17", "completion_date": "2022-04-19", "has_results": true, "last_update_posted_date": "2022-12-28", "last_synced_at": "2026-09-28T19:34:21.515Z", "location_count": 4, "location_summary": "Tucson, Arizona • Wichita, Kansas • Cincinnati, Ohio + 1 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02871297" }, { "nct_id": "NCT02709746", "title": "Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Depressive Disorder, Major" ], "interventions": [ { "name": "Vortioxetine 10 mg/day", "type": "DRUG" }, { "name": "Vortioxetine 20 mg/day", "type": "DRUG" }, { "name": "Fluoxetine 20 mg/day", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "H. Lundbeck A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 784, "start_date": "2016-05", "completion_date": "2019-07-30", "has_results": true, "last_update_posted_date": "2020-08-19", "last_synced_at": "2026-09-28T19:34:21.515Z", "location_count": 42, "location_summary": "Dothan, Alabama • Tucson, Arizona • Little Rock, Arkansas + 37 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Downey", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02709746" }, { "nct_id": "NCT01491035", "title": "Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Depressive Disorder", "Anxiety Disorder" ], "interventions": [ { "name": "Vortioxetine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "H. Lundbeck A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "7 Years to 17 Years" }, "enrollment_count": 48, "start_date": "2012-04", "completion_date": "2015-06", "has_results": true, "last_update_posted_date": "2017-03-16", "last_synced_at": "2026-09-28T19:34:21.515Z", "location_count": 4, "location_summary": "Washington D.C., District of Columbia • Wichita, Kansas • Cincinnatti, Ohio + 1 more", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Cincinnatti", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01491035" } ] }